Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 18, 2007

Ablynx Reaches Milestone with Proctor & Gamble

  • Ablynx reached a second milestone in its collaboration with Procter & Gamble Pharmaceuticals (P&GP). The company discovered novel Nanobodies® against a second target for possible new treatments in the musculoskeletal area. The first milestone was achieved in December 2006.

    As part of this on-going collaboration Ablynx is responsible for discovering nanobodies that meet an agreed product profile. P&GP is responsible for the pre-clinical and clinical development of Nanobodies®, as well as the commercialization of any resulting drug products.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »